When Should I Perform Point-of-Care Fluorescence Imaging of Wound Bioburden?

All Webcasts > When Should I Perform Point-of-Care Fluorescence Imaging of Wound Bioburden?
When Should I Perform Point-of-Care Fluorescence Imaging of Wound Bioburden? Guidelines based on Delphi Consensus

A Delphi Consensus was created to establish guidelines on fluorescence imaging of bacterial burden (MolecuLight i:X), the only point-of-care solution to visualize the presence of significant bacterial burden (>104 CFU/g) in wounds.
Join 5 of the authors of the Delphi Consensus as they discuss:
  • Clinical indications for fluorescence imaging (e.g., delayed wound healing, before and after debridement, before placement of cellular and tissue-based products)
  • Recommended frequency of fluorescence imaging
  • Real-world impact of fluorescence imaging on clinical decision making and associated wound outcomes

Fluorescence Imaging Guidelines

Videos Recommended for You

Utility of Point-of-Care Fluorescence for Detection of Elevated Bacterial Burden in an Outpatient Wound Care Setting
Bacterial Burden

Adopting Fluorescence Imaging for Detection of Elevated Bacterial Burdenas a Standard of Care in our Long-Term Care Facilities
Long Term Care Application

Learn more about our new Reimbursement Pathway

If you’d like to learn how the MolecuLight i:X can help your practice, you can book a demonstration here.

Check out our upcoming Webinars and Events